Abstract
4/2014
vol. 20
Case report
Response to low dose indomethacin in two children with nephrogenic diabetes insipidus
Pediatr Endocrinol Diabetes Metab 2014;22,4:178-181
Online publish date: 2015/08/31
Two children with nephrogenic diabetes insipidus (NDI) were treated with oral indomethacin (0.75-1.2 mg/kg/day) three times a day for a mean duration of 3 yrs. Remission occurred in both patients in terms of achieving a normal fluid balance and body growth and the drug was withdrawn in one patient after 2 yrs. The treatment was well tolerated and no side effects were noted. The mean duration of follow-up was 6.5 yrs. These long-term observations of a favourable response to low dose indomethacin in 2 children with NDI need to be tested on larger number of patients.
Keywords
nephrogenic diabetes insipidus, cyclooxygenase inhibitors, indomethacin, children
Integrated with
